RespiQ
RespiQ is a healthtech company founded in 2019 that develops a non-invasive, AI-enhanced handheld breathalyser for real-time health monitoring at home and point of care. Their proprietary algorithm analyzes breath biomarkers to create personalized health insights, enabling early detection of health issues such as COPD exacerbations and digestive health problems before symptoms occur. The device empowers users and clinicians with instant data for better health management and earlier medical intervention, aiming to improve wellbeing and reduce healthcare uncertainties. RespiQ operates with a subscription or device-based business model, collaborating with research institutions and partners to advance precision medicine and breath diagnostics.
RespiQ
RespiQ is a healthtech company founded in 2019 that develops a non-invasive, AI-enhanced handheld breathalyser for real-time health monitoring at home and point of care. Their proprietary algorithm analyzes breath biomarkers to create personalized health insights, enabling early detection of health issues such as COPD exacerbations and digestive health problems before symptoms occur. The device empowers users and clinicians with instant data for better health management and earlier medical intervention, aiming to improve wellbeing and reduce healthcare uncertainties. RespiQ operates with a subscription or device-based business model, collaborating with research institutions and partners to advance precision medicine and breath diagnostics.
TL;DR
Founded: 2019
Headquarters: Leiden / Amsterdam, The Netherlands
Product: Non-invasive AI-enhanced handheld breathalyser for real-time health monitoring
Focus: Detecting/monitoring respiratory disease (notably COPD) via VOC breath biomarkers
Funding highlights: Recipient of European Innovation Council support and other EU grants
Company Overview
Problem Domain
Respiratory disease detection and monitoring; broader breath-based diagnostics for medical and lifestyle applications.
Founded
2019
Industry
Biotechnology
Tech Stack
Funding Track Record
€4,000,000
EIC Pathfinder Challenge grant awarded to BreathSense consortium with RespiQ as lead/partner
Funding approved for an automation project under DIGI-B-CUBE H2020 program
Program support / accelerator affiliation
Investor Signal
“Antler, European Innovation Council, YES!Delft”